Qpex Biopharma
Latest round
- Series A
Last raised
- Oct 2018
Total raised
- $33M
Investors
- 6
About Qpex Biopharma
Founded in 2018 and headquartered in San Diego, US, Qpex Biopharma, Inc. develops anti-infectives aimed at treating infections caused by resistant pathogens. The company has undergone no significant pivots in its strategy and operates independently, without subsidiaries.Qpex Biopharma focuses on developing innovative therapies to combat antimicrobial resistance (AMR), addressing a critical global health threat. The company’s core product offerings include a pipeline of clinically proven anti-infectives, which are designed to target specific bacterial and fungal pathogens exhibiting resistance. These novel therapies are aimed at improving patient outcomes and enhancing the effectiveness of treatment options available to healthcare providers. Qpex's products are primarily targeted towards healthcare institutions, including hospitals and outpatient facilities, where infections caused by resistant pathogens pose significant challenges to patient care.Qpex Biopharma generates revenue through partnerships and collaborations with healthcare institutions and pharmaceutical companies, focusing on the delivery of its anti-infective therapies. The structure of transactions typically involves licensing agreements, where Qpex provides its proprietary technologies and drug formulations to partners in exchange for royalties or milestone payments based on development and sales performance. The company’s flagship products, including novel combinations like Xeruborbactam with Cefiderocol, are integral to its revenue model, aimed at addressing the urgent need for new antibiotics., LTD. for USD 140 mn, including USD 100 mn upfront and an additional USD 40 mn contingent upon achieving certain milestones. This transaction, expected to close by July 2023, will enhance Qpex's capabilities in drug and treatment development for infectious diseases.
Who invested in Qpex Biopharma
6 investors across 1 round
See all investors in Qpex Biopharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 16, 2018
Amount
$33M
Investors
Questions about Qpex Biopharma
Who invested in Qpex Biopharma?
Qpex Biopharma has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Qpex Biopharma raised?
Qpex Biopharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Qpex Biopharma last raise money?
Qpex Biopharma's most recent round on record is a Series A, in Oct 2018.
What does Qpex Biopharma do?
Founded in 2018 and headquartered in San Diego, US, Qpex Biopharma, Inc.
Where is Qpex Biopharma headquartered?
Qpex Biopharma is headquartered in San Diego, US.
Which VCs invest in companies like Qpex Biopharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Qpex Biopharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Qpex Biopharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.